Literature DB >> 24621397

Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?

Zoon Tariq1, Charlotte J Green, Leanne Hodson.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is not a single disease entity, rather it describes a spectrum of liver conditions that range from fatty liver (steatosis) to more severe steatosis coupled with marked inflammation and fibrosis [non-alcoholic steatohepatitis (NASH)] to severe liver disease such as cirrhosis and possibly hepatocellular carcinoma. Obesity, notably abdominal obesity, is a common risk factor for NAFLD. The pathogenesis from steatosis to NASH is poorly understood, and the 'two hit' model, as suggested nearly two decades ago, provides a feasible starting point for characterization of underlying mechanisms. This review will examine the oxidative stress factors ('triggers') which have been implicated as a 'second hit' in the development of primary NASH. It would be reasonable to assume that multiple, rather than single, pro-oxidative intracellular and extracellular triggers act in conjunction promoting oxidative stress that drives the development of NASH. It is likely that the common denominator of these pro-oxidative triggers is mitochondrial dysfunction. Understanding the contribution of each of these 'triggers' is an essential step in starting to understand and elucidate the mechanisms responsible for progression from steatosis to NASH, thus enabling the development of therapeutic targeting to prevent NASH development and progression.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NASH; anti-oxidant; liver; mitochondrial dysfunction; oxidative stress

Mesh:

Year:  2014        PMID: 24621397     DOI: 10.1111/liv.12523

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  36 in total

1.  Early redox imbalance is associated with liver dysfunction at weaning in overfed rats.

Authors:  E P S Conceição; E G Moura; J C Carvalho; E Oliveira; P C Lisboa
Journal:  J Physiol       Date:  2015-11-01       Impact factor: 5.182

Review 2.  The emerging role of mast cells in liver disease.

Authors:  Veronica Jarido; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Kristen Stephenson; Heather Francis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-04       Impact factor: 4.052

Review 3.  Lipid droplet functions beyond energy storage.

Authors:  Michael A Welte; Alex P Gould
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-07-19       Impact factor: 4.698

4.  Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p.

Authors:  Amanda Hanson; Ignazio S Piras; Danielle Wilhelmsen; Christopher D Still; Xin Chu; Anthony Petrick; Glenn S Gerhard; Johanna K DiStefano
Journal:  Cytokine       Date:  2019-07-25       Impact factor: 3.861

Review 5.  p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.

Authors:  Koji Taniguchi; Shinichiro Yamachika; Feng He; Michael Karin
Journal:  FEBS Lett       Date:  2016-08-06       Impact factor: 4.124

Review 6.  Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact.

Authors:  Chu-wen Lin; Xiao-li Huang; Hai-lin Liu; Yan Wang
Journal:  Dig Dis Sci       Date:  2015-06-26       Impact factor: 3.199

7.  Chrysin ameliorates nonalcoholic fatty liver disease in rats.

Authors:  Sarayu A Pai; Renuka P Munshi; Falguni H Panchal; Ila-Shruti Gaur; Archana R Juvekar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-01       Impact factor: 3.000

Review 8.  Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Authors:  Erin K Spengler; Rohit Loomba
Journal:  Mayo Clin Proc       Date:  2015-07-26       Impact factor: 7.616

Review 9.  P2X7 receptor as a key player in oxidative stress-driven cell fate in nonalcoholic steatohepatitis.

Authors:  Saurabh Chatterjee; Suvarthi Das
Journal:  Oxid Med Cell Longev       Date:  2015-03-01       Impact factor: 6.543

Review 10.  The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.

Authors:  Sílvia S Chambel; Andreia Santos-Gonçalves; Tiago L Duarte
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.